Patents by Inventor David Andreu

David Andreu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240059737
    Abstract: The present invention relates to compounds of formula (I) AA1-AA2-D-Ile-AA3-D-Met-D-Tyr-D-Ala-D-Tyr-D-Val-D- Ala-Gly-D-Ile-D-Leu-D-Lys-D-Arg-D-Trp-NH2 (I) or a pharmaceutically acceptable salts thereof, to processes for their obtention and to their therapeutic indications.
    Type: Application
    Filed: October 2, 2020
    Publication date: February 22, 2024
    Inventors: Vicent CASADÓ BURILLO, Estefania MORENO GUILLEN, Rafael MALDONADO LÓPEZ, David ANDREU MARTINEZ, Maria GALLO, Leonardo PARDO CARRASCO, Miguel CASTANHO, Vera NEVES, Marco CAVACO
  • Publication number: 20230364431
    Abstract: An active implantable medical device including, once implanted, a module external to the patient and a module inside the patient, the external module and the internal module being intended to transfer energy and data from one to the other. Also, a method for transferring energy and data, the method being implemented by the active implantable medical device.
    Type: Application
    Filed: September 24, 2021
    Publication date: November 16, 2023
    Applicants: NEURINNOV, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INRIA - INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET EN AUTOMATIQUE, UNIVERSITÉ DE MONTPELLIER
    Inventors: David ANDREU, David GUIRAUD, Brice SORLI, Arnaud VENA
  • Patent number: 10487117
    Abstract: A novel antimicrobial peptide is provided having an inhibitory effect on biofilms produced by biofilm-forming bacteria. The peptide is effective against wide range bacterial targets; generates no antimicrobial resistance; agglutinates bacteria cells enhancing the pathogen removal at the infectious focus; promotes biofilm eradication and prevents biofilm development. Compositions comprising the peptide are provided to treat and prevent infectious diseases, and for other uses such as the disinfection of medical and surgical materials.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: November 26, 2019
    Assignees: UNIVERSITAT AUTONOMA DE BARCELONA, UNIVERSITAT POMPEU FABRA
    Inventors: Ester Boix Borrás, Marc Torrent Burgas, David Andreu
  • Publication number: 20180222943
    Abstract: A novel antimicrobial peptide is provided having an inhibitory effect on biofilms produced by biofilm-forming bacteria. The peptide is effective against wide range bacterial targets; generates no antimicrobial resistance; agglutinates bacteria cells enhancing the pathogen removal at the infectious focus; promotes biofilm eradication and prevents biofilm development. Compositions comprising the peptide are provided to treat and prevent infectious diseases, and for other uses such as the disinfection of medical and surgical materials.
    Type: Application
    Filed: July 28, 2016
    Publication date: August 9, 2018
    Applicants: UNIVERSITAT AUTONOMA DE BARCELONA, UNIVERSITAT POMPEU FABRA
    Inventors: Ester BOIX BORRÁS, Marc TORRENT BURGAS, David ANDREU
  • Patent number: 9855428
    Abstract: A device includes a pulse generator coupled to a neurostimulation lead placed around the nerve and a set of electrodes individually connected to the generator by a splitter circuit controlled to preferentially stimulate certain regions of the nerve relative to other regions. The device performing an iterative search of an optimal configuration operating by selection of a plurality of different stimulation configurations, storing of a cardiac physiological parameter measured for each selected stimulation configuration, and designation as optimal stimulation configuration of the one of said selected different stimulation configurations, depending on at least the stored values of the physiological parameter measured for different electrode configurations.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: January 2, 2018
    Assignees: SORIN CRM SAS, INRIA—Institut National de Recherche en Informatique et en Automatique
    Inventors: Christine Henry, Laure Laporte-Duchemin, David Andreu, Christine Azevedo-Coste, David Guiraud, Pawel Maciejasz, Olivier Rossel
  • Publication number: 20170304621
    Abstract: A method for stimulating vagal neurons as demonstrated by generation of action potentials on these same neurons, wherein electrical pulse trains are periodically applied to electrodes implanted on the anterior and posterior vagus nerve at an entrance of a diaphragm, wherein each electrical pulse train is formed by a plurality of monophasic pulses having a frequency of at least 13.0 kHz.
    Type: Application
    Filed: September 23, 2015
    Publication date: October 26, 2017
    Inventors: Charles-Henri Malbert, Jean-Louis Divoux, David Guiraud, David Andreu
  • Publication number: 20160331975
    Abstract: A device includes a pulse generator coupled to a neurostimulation lead placed around the nerve and a set of electrodes individually connected to the generator by a splitter circuit controlled to preferentially stimulate certain regions of the nerve relative to other regions. The device performing an iterative search of an optimal configuration operating by selection of a plurality of different stimulation configurations, storing of a cardiac physiological parameter measured for each selected stimulation configuration, and designation as optimal stimulation configuration of the one of said selected different stimulation configurations, depending on at least the stored values of the physiological parameter measured for different electrode configurations.
    Type: Application
    Filed: July 29, 2016
    Publication date: November 17, 2016
    Applicants: SORIN CRM SAS, INRIA- Institut National de Recherche en Informatique et en Automatique
    Inventors: Christine Henry, Laure Laporte-Duchemin, David Andreu, Christine Azevedo-Coste, David Guiraud, Pawel Maciejasz, Olivier Rossel
  • Patent number: 9403012
    Abstract: A device includes a pulse generator coupled to a neurostimulation lead placed around the nerve and a set of electrodes individually connected to the generator by a splitter circuit controlled to preferentially stimulate certain regions of the nerve relative to other regions. The device performing an iterative search of an optimal configuration operating by selection of a plurality of different stimulation configurations, storing of a cardiac physiological parameter measured for each selected stimulation configuration, and designation as optimal stimulation configuration of the one of said selected different stimulation configurations, depending on at least the stored values of the physiological parameter measured for different electrode configurations.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: August 2, 2016
    Assignee: SORIN CRM SAS
    Inventors: Christine Henry, Laure Laporte-Duchemin, David Andreu, Christine Azevedo-Coste, David Guiraud, Pawel Maciejasz, Olivier Rossel
  • Publication number: 20150328464
    Abstract: A device includes a pulse generator coupled to a neurostimulation lead placed around the nerve and a set of electrodes individually connected to the generator by a splitter circuit controlled to preferentially stimulate certain regions of the nerve relative to other regions. The device performing an iterative search of an optimal configuration operating by selection of a plurality of different stimulation configurations, storing of a cardiac physiological parameter measured for each selected stimulation configuration, and designation as optimal stimulation configuration of the one of said selected different stimulation configurations, depending on at least the stored values of the physiological parameter measured for different electrode configurations.
    Type: Application
    Filed: May 15, 2015
    Publication date: November 19, 2015
    Inventors: Christine Henry, Laure Laporte-Duchemin, David Andreu, Christine Azevedo-Coste, David Guiraud, Pawel Maciejasz, Olivier Rossel
  • Patent number: 8792835
    Abstract: A system and method for wirelessly testing integrated circuits provides a multiple layer interface to wirelessly test integrated circuits. A wireless testing structure for an integrated circuit comprises a wireless transceiver and a wireless test interface. The wireless transceiver is configured to receive test information from a tester and transmit test result information to the tester. The wireless test interface is configured to interface between the wireless transceiver and the integrated circuit. The wireless test interface comprises a media access controller and a test control block. The media access controller is configured to implement a media access control protocol for wireless communication. The test control block is configured to decode test information received from the tester, to trigger a test of the integrated circuit in response to the decoded test information, and to encode test result information that is generated by the integrated circuit in response to the test.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: July 29, 2014
    Assignee: Centre National de la Recherche Scientifique
    Inventors: David Andreu, Philippe Cauvet, Marie-Lise Flottes, Ziad Noun, Serge Bernard
  • Patent number: 8738146
    Abstract: A control device implantable in a human body—includes a control unit and at least one electrode, said control unit being connected to each electrode to control stimulation and/or measurement thereof. The control unit includes: a timing dock; a memory storing configuration data defined to enable configuration of each electrode correlated with identifiers; a memory storing program data describing a time profile correlated with identifiers; an executor activatable to send each electrode electric pulses corresponding to a predetermined program according to a predetermined electrode configuration, according to the clock; a sequencer arranged to receive an ordered plurality of pairs, each including an electrode configuration identifier and a program identifier, and selectively to activate the executor with the electrode and program configuration pairs denoted by the pairs of identifiers received as an input, according to the order thereof and the clock.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: May 27, 2014
    Assignees: Inria Institut National de Recherche en Informatique et en Automatique, Obelia, Centre National de la Recherche Scientifique (C.N.R.S)
    Inventors: David Guiraud, David Andreu, Guy Charvin, Jean-Louis Divoux
  • Publication number: 20130110200
    Abstract: A control device implantable in a human body—includes a control unit and at least one electrode, said control unit being connected to each electrode to control stimulation and/or measurement thereof. The control unit includes: a timing dock; a memory storing configuration data defined to enable configuration of each electrode correlated with identifiers; a memory storing program data describing a time profile correlated with identifiers; an executor activatable to send each electrode electric pulses corresponding to a predetermined program according to a predetermined electrode configuration, according to the clock; a sequencer arranged to receive an ordered plurality of pairs, each including an electrode configuration identifier and a program identifier, and selectively to activate the executor with the electrode and program configuration pairs denoted by the pairs of identifiers received as an input, according to the order thereof and the clock.
    Type: Application
    Filed: April 15, 2011
    Publication date: May 2, 2013
    Applicants: Inria Institut National de Recherche en Informatique et an Automatique, Centre National de la Recherche, Obelia, Universite Montpellier 2 Sciences et Techniques
    Inventors: David Guiraud, David Andreu, Guy Charvin, Jean-Louis Divoux
  • Publication number: 20110244814
    Abstract: A system and method for wirelessly testing integrated circuits provides a multiple layer interface to wirelessly test integrated circuits. A wireless testing structure for an integrated circuit comprises a wireless transceiver and a wireless test interface. The wireless transceiver is configured to receive test information from a tester and transmit test result information to the tester. The wireless test interface is configured to interface between the wireless transceiver and the integrated circuit. The wireless test interface comprises a media access controller and a test control block. The media access controller is configured to implement a media access control protocol for wireless communication. The test control block is configured to decode test information received from the tester, to trigger a test of the integrated circuit in response to the decoded test information, and to encode test result information that is generated by the integrated circuit in response to the test.
    Type: Application
    Filed: September 22, 2009
    Publication date: October 6, 2011
    Applicant: Centre National de la Recherche Scientifique - CNRS-
    Inventors: David Andreu, Philippe Cauvet, Marie-Lise Flottes, Ziad Noun, Serge Bernard
  • Patent number: 7768151
    Abstract: A device (ES) for distributing power between n cathodes (Ki) of at least one multipolar stimulating electrode (EM) comprises at least one anode (A), wherein n is equal to or greater than two. Said device (ES) comprises a reconfigurable current mirror (MC) which is provided with n outputs (K?i) connectable to said n cathodes (Ki), respectively and supplies to the n (K?i) outputs n complementary fractions of a control current having respective selected values which are substantially constant at the control current amplitude variation in order to carry out a substantially constant spatial location of stimulation.
    Type: Grant
    Filed: August 29, 2005
    Date of Patent: August 3, 2010
    Assignees: Inria Institut National de Recherche en Informatique et en Automatique, Centre National de la Recherche Scientifique CNRS, Universite de Montpellier II
    Inventors: David Andreu, Serge Bernard, Yves Bertrand, Guy Catheras, Jérôme Galy, David Guiraud, Jean-Denis Techer
  • Publication number: 20080061630
    Abstract: A device (ES) for distributing power between n cathodes (Ki) of at least one multipolar stimulating electrode (EM) comprises at least one anode (A), wherein n is equal to or greater than two. Said device (ES) comprises a reconfigurable current mirror (MC) which is provided with n outputs (K?i) connectable to said n cathodes (Ki), respectively and supplies to the n (K?i) outputs n complementary fractions of a control current having respective selected values which are substantially constant at the control current amplitude variation in order to carry out a substantially constant spatial location of stimulation.
    Type: Application
    Filed: August 29, 2005
    Publication date: March 13, 2008
    Inventors: David Andreu, Serge Bernard, Yves Bertrand, Guy Catheras
  • Patent number: 5739272
    Abstract: A procedure for obtaining carbocalcitonin comprising the condensation of fragment 1, a docosapeptide corresponding to the carboxamide end of the carbocalcitonin sequence, conveniently protected and anchored on resin, with fragment 2 or 3, a nonapeptide corresponding to the amino end of the salmon calcitonin sequence, with a ready-formed cycle between the Asu and Ser residua, and the treatment of the complete peptide skeleton (fragment 6 or 7) with an acid to free the totally deprotected peptide from the resin.
    Type: Grant
    Filed: February 3, 1994
    Date of Patent: April 14, 1998
    Assignee: Lipotec, S.A.
    Inventors: Marcos Canas Poblet, Berta Ponsati Obiols, Gemma Jodas Farres, David Andreu Martinez
  • Patent number: 5714467
    Abstract: The invention relates to antibacterial and antimalarial peptides which are hybrids peptides which a of naturally occurring peptides such as cecropins, attacins, magainins, sarcotoxin, sapecin, bactenecins, alamethidicins, defensins and PGLa, and toxins such as streptolysins, melittin, barbatolysin, paradaxins and delta hemolysin. The hybrid peptides of the present invention are easily synthesized and have reduced toxicity. Also included in the invention are pharmaceutical compositions containing such hybrid peptides, and methods of treating patients infected with an organism against which these peptides are active.
    Type: Grant
    Filed: March 26, 1993
    Date of Patent: February 3, 1998
    Assignee: The Rockefeller University
    Inventors: Hans G. Boman, Robert B. Merrifield, David Andreu